ArticleMolecular biology reports2026
Haplotype structure and functional genotype-phenotype interactions of PON1 (L55M/Q192R) variants in Egyptian children with nephrotic syndrome.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNephrotic syndrome (NS) is characterized by proteinuria, hypoalbuminemia, and dyslipidemia. Paraoxonase-1 (PON1), an HDL-associated antioxidant enzyme, contributes to lipid protection and redox homeostasis.
objectivesTo investigate the associations of PON1 L55M (rs854560) and Q192R (rs662) polymorphisms with NS and their relationships with PON1 concentrations in an Egyptian pediatric cohort. PATIENTS AND
methodsThis case-control study included 84 children aged 4-12 years: 42 with NS and 42 age- and sex-matched healthy controls. Serum PON1 concentration, lipid profile, albumin, blood urea, and urinary albumin excretion were assessed. PON1 polymorphisms were genotyped using tetra-primer amplification refractory mutation system polymerase chain reaction (T-ARMS-PCR).
resultsChildren with NS had higher total cholesterol, LDL cholesterol, triglycerides, blood urea, and urinary albumin excretion, and lower HDL cholesterol, albumin, and PON1 concentrations than controls (all p < 0.001). The L55M MM genotype was more frequent in NS than controls (66.7% vs. 40.5%; OR = 3.77, p = 0.02) and was associated with an adverse biochemical profile. For Q192R, the R allele was associated with NS (61.9% vs. 42.9%; OR = 2.17, p = 0.01), while the RR genotype showed an association under the recessive model (OR = 2.67, p = 0.04). MM and RR carriers had the lowest PON1 concentrations. Haplotype analysis suggested associations between the LQ and MR haplotypes and NS.
conclusionsPON1 genetic variation and reduced PON1 concentrations may contribute to the metabolic phenotype and susceptibility to NS, supporting a potential role for PON1-mediated antioxidant pathways in disease pathophysiology and variation in oxidative stress responses among children.
Indexed as
Identifiers
42891870What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.